Unlearn.AI Revenue and Competitors
Estimated Revenue & Valuation
- Unlearn.AI's estimated annual revenue is currently $12.9M per year.
- Unlearn.AI's estimated revenue per employee is $140,000
- Unlearn.AI's total funding is $135M.
- Unlearn.AI's current valuation is $265M. (March 2023)
Employee Data
- Unlearn.AI has 92 Employees.
- Unlearn.AI grew their employee count by 23% last year.
Unlearn.AI's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder | Reveal Email/Phone |
2 | Founder and CEO | Reveal Email/Phone |
3 | Chief Staff to the CEO | Reveal Email/Phone |
4 | Head Business Development | Reveal Email/Phone |
5 | Head People | Reveal Email/Phone |
6 | Head Platform | Reveal Email/Phone |
7 | VP Technology | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | Director Business Development | Reveal Email/Phone |
10 | Data Scientist | Reveal Email/Phone |
Unlearn.AI Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $27M | 175 | 26% | N/A | N/A |
#2 | $0.2M | 3 | -70% | N/A | N/A |
#3 | $4.6M | 41 | -20% | N/A | N/A |
#4 | $7.3M | 60 | -32% | $11.6M | N/A |
#5 | $3.6M | 34 | 0% | $11.4M | N/A |
#6 | $5.2M | 46 | -15% | N/A | N/A |
#7 | $0.8M | 10 | N/A | N/A | N/A |
#8 | $14.1M | 101 | -13% | $21.5M | N/A |
#9 | $1.4M | 17 | N/A | N/A | N/A |
#10 | $4.4M | 39 | 11% | N/A | N/A |
What Is Unlearn.AI?
Accelerating clinical trials with AI. It's about time.
keywords:N/A
$135M
Total Funding
92
Number of Employees
$12.9M
Revenue (est)
23%
Employee Growth %
$265M
Valuation
N/A
Accelerator
Unlearn.AI News
Unlearn works with pharma sponsors, biotech companies, and academic institutions to optimize human clinical trials with TwinRCTs.
Unlearn.AI, a startup developing 'digital twin' technology for clinical trial applications, has raised $60 million in a venture round led by...
Unlearn.AI's Series B round follows a positive European Medicines Agency draft opinion finding that the company's artificial intelligence...
Our goal is to reduce clinical trial timelines as much as possible, while producing robust and reliable evidence - Charles Fisher, Ph.D., founder and CEO of Unlearn.AI LOS ANGELES (PRWEB) October 27, 2021 BioTech Breakthrough, a leading independent market intelligence organization that evaluat ...
Unlearn, a San Francisco, CA-based developer of a machine-learning platform that creates Digital Twins used to populate Intelligent Control Arms in clinical studies, raised an approx. $3m Series A extension funding round. Backers included Eisai, Epic Ventures and Alumni Ventures Group. In Apri ...
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $18.9M | 92 | 8% | N/A |
#2 | $18.5M | 92 | 8% | N/A |
#3 | $18.6M | 92 | 8% | N/A |
#4 | $15M | 92 | 6% | N/A |
#5 | $19.3M | 92 | -8% | $20M |